Evidence map›Paper›PMID 40547011›Full record

ArticleFrontiers in immunology2025

Whole-cell response of coronavirus-infected BMDCs through proteomic and transcriptomic analyses.

Yanxi Ji, Yuzhen Zhang, Yongjia Tong, Liu Cao, Lanyi Zeng, Yiran Xu, Xiao Guo, Tiefeng Xu, Zhidong Tang, Zhen Zhang and 5 more

Abstract read
In one paragraph

Article in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Yanxi JiState Key Laboratory of Virology and Biosafety, Modern Virology Research Center and RNA Institute, College of Life Sciences and Frontier Science Center for Immunology and Metabolism, Wuhan University, Wuhan, China.
Yuzhen ZhangState Key Laboratory of Virology and Biosafety, Modern Virology Research Center and RNA Institute, College of Life Sciences and Frontier Science Center for Immunology and Metabolism, Wuhan University, Wuhan, China.
Yongjia TongState Key Laboratory of Virology and Biosafety, Modern Virology Research Center and RNA Institute, College of Life Sciences and Frontier Science Center for Immunology and Metabolism, Wuhan University, Wuhan, China.
Liu CaoCentre for Infection and Immunity Studies (CIIS), School of Medicine, Shenzhen Campus of Sun Yat-sen University, Guangzhou, China.
Lanyi ZengState Key Laboratory of Virology and Biosafety, Modern Virology Research Center and RNA Institute, College of Life Sciences and Frontier Science Center for Immunology and Metabolism, Wuhan University, Wuhan, China.
Yiran XuState Key Laboratory of Virology and Biosafety, Modern Virology Research Center and RNA Institute, College of Life Sciences and Frontier Science Center for Immunology and Metabolism, Wuhan University, Wuhan, China.
Xiao GuoState Key Laboratory of Virology and Biosafety, Modern Virology Research Center and RNA Institute, College of Life Sciences and Frontier Science Center for Immunology and Metabolism, Wuhan University, Wuhan, China.
Tiefeng XuCentre for Infection and Immunity Studies (CIIS), School of Medicine, Shenzhen Campus of Sun Yat-sen University, Guangzhou, China.
Zhidong TangState Key Laboratory of Virology and Biosafety, Modern Virology Research Center and RNA Institute, College of Life Sciences and Frontier Science Center for Immunology and Metabolism, Wuhan University, Wuhan, China.
Zhen ZhangState Key Laboratory of Virology and Biosafety, Modern Virology Research Center and RNA Institute, College of Life Sciences and Frontier Science Center for Immunology and Metabolism, Wuhan University, Wuhan, China.
Lin GuoState Key Laboratory of Virology and Biosafety, Modern Virology Research Center and RNA Institute, College of Life Sciences and Frontier Science Center for Immunology and Metabolism, Wuhan University, Wuhan, China.
Deyin GuoGuangzhou Laboratory, Bio-island, Guangzhou, Guangdong, China.
Huabin ZhaoState Key Laboratory of Virology and Biosafety, Modern Virology Research Center and RNA Institute, College of Life Sciences and Frontier Science Center for Immunology and Metabolism, Wuhan University, Wuhan, China.
Yu ChenState Key Laboratory of Virology and Biosafety, Modern Virology Research Center and RNA Institute, College of Life Sciences and Frontier Science Center for Immunology and Metabolism, Wuhan University, Wuhan, China.
Xiaolu ZhaoState Key Laboratory of Virology and Biosafety, Modern Virology Research Center and RNA Institute, College of Life Sciences and Frontier Science Center for Immunology and Metabolism, Wuhan University, Wuhan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Understanding the intricacies of the host inflammatory response to coronaviruses is essential for developing effective therapeutic strategies to mitigate the severe consequences of these infections. Various coronaviruses can trigger the host immune response, leading to highly similar inflammatory reactions. The mouse hepatitis virus (MHV), which belongs to the same group of beta-coronaviruses as SARS-CoV-2 and induces high pathogenicity in mice, typically serves as a safety model for investigating highly pathogenic coronavirus infections, replication, and virus-host interactions. Methods: In this study, we conducted a comprehensive analysis of the transcriptome and proteome of mouse bone marrow dendritic cells (BMDCs) infected with MHV. Results: We characterized the global gene changes at both the mRNA and protein levels following viral infection, identifying ten genes involved in various anti-MHV biological processes. Furthermore, by integrating our findings with relevant published data on SARS-CoV-2 infection in cells, we observed significant similarities in the responses to MHV and SARS-CoV-2, particularly regarding immune and inflammatory responses. Discussion: These findings underscore how our research enhances the understanding of global gene expression alterations during coronavirus infection and facilitates the identification of novel antiviral targets.

Indexed as

Dendritic CellsMurine hepatitis virusProteomeSARS-CoV-2TranscriptomeAnimalsCOVID-19Gene Expression ProfilingHost-Pathogen InteractionsMiceMice, Inbred C57BLProteomicsProteomeBMDCsinnate immunitymouse hepatitis virusproteomicsSARS-CoV-2transcriptomicsvirus-host interaction

Identifiers

PMID40547011
PMCPMC12180443

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.